Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

Objective: To evaluate the effect of metformin on blood pressure and insulin sensitivity in non-diabetic, moderately obese, hypertensive patients. Patients and Methods: An 8-week double-blind ...

In recent years, there have been more developments in the area of diabetes management, with the emergence of metformin and more recently semaglutide and dulaglutide. However, despite these ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Nippon India Small Cap Fund (B) 467.76 29,95,942 0.92 Nippon India Small Cap Fund (IDCW) 467.76 29,95,942 0.92 Nippon India Small Cap Fund (G) 467.76 29,95,942 0.92 ...

Zydus Lifesciences Ltd. is a Public Limited Listed company incorporated on 15/05/1995 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is ...

Zydus Wellness Ltd., incorporated in the year 1994, is a Mid Cap company (having a market cap of Rs 10,611.30 Crore) operating in FMCG sector. Zydus Wellness Ltd. key Products/Revenue Segments include ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.